Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-054828
Filing Date
2025-06-16
Accepted
2025-06-16 17:08:51
Documents
73
Period of Report
2025-04-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0245769-10q_enzobio.htm   iXBRL 10-Q 753010
2 CERTIFICATION ea024576901ex31-1_enzobio.htm EX-31.1 9926
3 CERTIFICATION ea024576901ex31-2_enzobio.htm EX-31.2 9894
4 CERTIFICATION ea024576901ex32-1_enzobio.htm EX-32.1 3816
5 CERTIFICATION ea024576901ex32-2_enzobio.htm EX-32.2 3380
  Complete submission text file 0001213900-25-054828.txt   5432393

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE enz-20250430.xsd EX-101.SCH 41724
7 XBRL CALCULATION FILE enz-20250430_cal.xml EX-101.CAL 51509
8 XBRL DEFINITION FILE enz-20250430_def.xml EX-101.DEF 243540
9 XBRL LABEL FILE enz-20250430_lab.xml EX-101.LAB 460334
10 XBRL PRESENTATION FILE enz-20250430_pre.xml EX-101.PRE 266776
76 EXTRACTED XBRL INSTANCE DOCUMENT ea0245769-10q_enzobio_htm.xml XML 696429
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 251051030
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)